Please login to the form below

Not currently logged in
Email:
Password:

market access

This page shows the latest market access news and features for those working in and with pharma, biotech and healthcare.

NICE gives Lilly’s Verzenios chance to compete with rivals

NICE gives Lilly’s Verzenios chance to compete with rivals

Lilly got the green light after improving its price offering via a revised patient access scheme, and NICE says it is now cost effective relative to the other treatments in the ... Ibrance (palbociclib) was the first of these drugs to reach the market

Latest news

More from news
Approximately 115 fully matching, plus 382 partially matching documents found.

Latest Intelligence

  • The UK’s new five-year pricing agreement The UK’s new five-year pricing agreement

    Mike Thompson, chief executive, ABPI. Having agreed a ceiling on growth, the question of speed of market access for novel treatments will undoubtedly be the key metric preoccupying UK industry leaders ... Routes to market. A single, shared approach to

  • Launch excellence: beyond the six-month mantra Launch excellence: beyond the six-month mantra

    a compelling message that will drive the behaviour change we seek; is our value proposition sufficient to secure price and market access?

  • Launch like a PRO: the art and science of successful entry to market Launch like a PRO: the art and science of successful entry to market

    From strategy to project management, market access to public affairs, governance to HEOR, they provide an incredibly thorough test of an organisation’s capability. ... Read any article on launch and the chances are it will major on patient-centricity,

  • Relearning launch: Four key dynamics for pharma launches in 2019 Relearning launch: Four key dynamics for pharma launches in 2019

    The changing reimbursement landscape has been a big driver of this trend with many payers automatically assigning new-to market blocks at launch to manage access to costly new products. ... They’ll leverage market simulation and testing to develop

  • Is China ready for a pharmaceutical gold rush?

    Indeed, BMS will pitch Opdivo at half the US list price, determining the true value of market access. ... Public trading barometer. Another potential barometer of China’s free market access will be how the sector fares on the Hong Kong Stock exchange.

More from intelligence
Approximately 56 fully matching, plus 121 partially matching documents found.

Latest appointments

  • New starters join Four Communications, Emotive and McCann Health New starters join Four Communications, Emotive and McCann Health

    Jones, who also joins the Four Communications Group operating board, joined the team in 2012, and has worked across the company’s market access, corporate communications and campaign functions. ... Cambers joined Insight back in 2009, and specialises

  • Weekly comms appointments Weekly comms appointments

    market access practices.

  • ProPharma selects new CEO and president ProPharma selects new CEO and president

    She has also held the role of chief operating officer for Teva Pharmaceuticals, where her focus included strategy and innovation for patient solutions, commercial effectiveness, market access, business insights and market

  • Open Access Consulting appoints new director Open Access Consulting appoints new director

    Hurrell joins the group from Evidera, where she worked for over a decade, most recently as vice president and EU practice lead, market access communications. ... In this role, Hurrell oversaw the team’s market access communications offering, supporting

  • Claes Buxfeldt joins NDA Claes Buxfeldt joins NDA

    He has represented the payer voice in development programmes including the development of payer evidence strategies, pricing, market access strategy, economic models and clinical programme input.

More from appointments
Approximately 4 fully matching, plus 87 partially matching documents found.

Latest from PMHub

  • Meet Porterhouse Medical at the ISMPP EU meeting 2019 in London 22 - 23 January

    Porterhouse Medical’s strategic publication planning experts are participating in two events at the 2019 European Meeting of the International Society for Medical Publication Professionals, entitled: 'Scientific communications in a fast-paced world

  • Maloff Mosquito

    Product: Maloff Protect. Client: Glenmark Pharmaceuticals. Therapy area: OTC Products. View the PMHub profile for: Hamell.

  • Porterhouse Medical rewards superb client service skills

    Porterhouse Medical is delighted to announce the promotion of Gema Noguera to senior account director. Since joining the client services team as a senior account executive in 2013, Gema has consistently demonstrated her superb client service skills

  • New opportunities in emerging markets

    This growth is set to continue. In parallel, we are seeing an increased focus among emerging market governments on public healthcare reform: expanding their populations’ access to medicines by establishing universal ... Greater purchasing power and

  • Digital applications are transforming the market access landscape

    New cloud technology provides an improved framework for real-time decision-making in market access. ... Only then can you ensure that your company fully unlocks and optimises product value and elevates their market access competitiveness.

More from PMHub
Approximately 26 fully matching, plus 339 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Fendix

Latest intelligence

NHS regional footprints
What to expect from 2019...
Not another weight-loss ad
Christmas is over and the gyms are packed, it’s a never-ending tale. But why do we do it to ourselves every year?...
China’s clinical trial shake-up
As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...

Infographics